Mark Schoenberg is Chief Medical Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 139,025 shares of URGN, which is worth approximately $3.38 Million. The most recent transaction as insider was on Oct 26, 2020, when has been sold 208 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 139K
6.71% 3M change
4.18% 12M change
Total Value Held $3.38 Million

Mark Schoenberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 26 2020
BUY
Exercise of conversion of derivative security
-
208 Added 1.06%
19,444 Ordinary Shares
MS

Mark Schoenberg

Chief Medical Officer
Princeton, NJ

Track Institutional and Insider Activities on URGN

Follow UroGen Pharma Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

News

Receive news related to UroGen Pharma Ltd.

Track Activities on URGN